Management of the pregnant patient by the rheumatologist

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Rheumatic disorders are more common in women. Thus, clinicians may be faced with the challenge of managing a rheumatic disease during pregnancy. The physiological and immunological changes that occur in pregnancy can impact disease symptoms and activity. An integrated team approach that relies on input from the rheumatologist, maternal-fetal medicine specialist, and the patient, is the best insurance for a good outcome. Treatment regimens must be modified as not all medications are compatible with pregnancy. In general, nonsteroidal anti-inflammatory drugs up to the third trimester, glucocorticoids, antimalarials, sulfasalazine, and the immunosuppressive agents azathioprine and cyclosporine A may be used during pregnancy while methotrexate, leflunomide, cyclophosphomide, and the biologics should be avoided. Copyright Remedica Medical Education and Publishing.

Original languageEnglish (US)
Pages (from-to)115-122
Number of pages8
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number4
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Management of the pregnant patient by the rheumatologist'. Together they form a unique fingerprint.

Cite this